Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-26

Clinical Trial Update: Morbid Rates After Spiriva Chronic Obstructive Pulmonary Disease (COPD) Protocol Change

View source ↗

Summary

A completed clinical trial evaluating morbid rates after a protocol change for Spiriva in chronic obstructive pulmonary disease; results were posted on 2024-10-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spiriva (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Status: COMPLETED | Results posted: 2024-10-26